Estimation of an optimal radiotherapy utilization rate for gynecologic carcinoma: Part I - Malignancies of the cervix, ovary, vagina, and vulva

Cancer

Volumn 101, Issue 4, 2004, Pages 671-681

  Delaney, Geoff ^a   Jacob, Susannah ^a   Barton, Michael ^a  

^a LIVERPOOL HOSPITAL   (Australia)

Author keywords

Cervical carcinoma; Ovarian carcinoma; Radiotherapy; Radiotherapy utilization; Vaginal carcinoma; Vulvar carcinoma

Indexed keywords

AUSTRALIA; CANCER CLASSIFICATION; CANCER PATIENT; CANCER RADIOTHERAPY; CONTROLLED STUDY; EVIDENCE BASED MEDICINE; EXPERT SYSTEM; FEMALE; GYNECOLOGIC CANCER; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; OVARY CANCER; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; STATISTICAL ANALYSIS; TREATMENT INDICATION; UTERINE CERVIX CANCER; VAGINA CANCER; VULVA CANCER;

BENCHMARKING; CARCINOMA; EVIDENCE-BASED MEDICINE; FEMALE; GENITAL NEOPLASMS, FEMALE; GUIDELINE ADHERENCE; HUMANS; INCIDENCE; INTERNATIONAL COOPERATION; PATIENT SELECTION; PRACTICE GUIDELINES; RADIOTHERAPY;

EID: 3543072235     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20444     Document Type: Review

References (50)

1. Tyldesley S, Boyd C, Shulze K, Walker H, Mackillop WJ. Estimating the need for radiotherapy for lung cancer: an evidence-based, epidemiologic approach. Int J Radiat Oncol Biol Phys. 2001;49:973-985.
2. Delaney G, Barton M, Jacob S, Jalaludin B. A model for decision making for the use of radiotherapy in lung cancer. Lancet Oncol. 2003;4:120-128.
3. Delaney G, Barton B, Jacob S. Estimation of an optimal radiotherapy utilization rate for breast cancer: a review of the evidence. Cancer. 2003;98:1977-1986.
4. Foroudi F, Tyldesley S, Walker H, Mackillop WJ. An evidence-based estimate of appropriate radiotherapy utilization rate for breast cancer. Int J Radiat Oncol Biol Phys. 2002;53:1240-1253.
5. Delaney G, Barton M, Jacob S. Estimation of an optimal radiotherapy utilization rate for melanoma. A review of the evidence. Cancer. 2004;100:1293-1301.
6. Foroudi F, Tyldesley S, Barbera L, Huang J, Mackillop WJ. An evidence-based estimate of the appropriate radiotherapy utilization rate for colorectal cancer. Int J Radiat Oncol Biol Phys. 2003;56:1295-1307.
7. Foroudi F, Tyldesley S, Barbera L, Huang J, Mackillop WJ. Evidence-based estimate of appropriate radiotherapy utilization rate for prostate cancer. Int J Radiat Oncol Biol Phys. 2003;55:51-63.
8. National Cancer Institute. PDQ cancer information summaries: treatment of cervical cancer [monograph online]. Available from URL: http://www.cancer.gov/ cancerinfo/pdq/treatment/cervical/healthprofessional/ [accessed Oct 16 2001].
9. National Cancer Institute. PDQ cancer information summaries: treatment of vulvar cancer [monograph online]. Available from URL: http://www.cancer.gov/ cancerinfo/pdq/treatment/vulvar/healthprofessional/ [accessed Mar 8, 2002].
10. National Cancer Institute. PDQ cancer information summaries: treatment of vaginal cancer [monograph online]. Available from URL: http://www.cancer.gov/ cancerinfo/pdq/treatment/vaginal/healthprofessional/ [accessed Mar 8, 2002].
11. National Cancer Institute. PDQ cancer information summaries: treatment of ovarian cancer [monograph online]. Available from URL: http://www.cancer.gov/ cancerinfo/pdq/treatment/ovarianepithelial/healthprofessional/ [accessed Mar 23, 2002].
12. National Institutes of Health. Consensus statement: National Institutes of Health Consensus Development Conference statement on cervical cancer. Gynecol Oncol. 1997;66:351-361.
13. FIGO Committee on Gynecologic Oncology. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. Int J Gynaecol Obstet. 2000;70:209-262.
14. BC Cancer Agency. Cancer management guidelines: cervical cancer [monograph online]. Available from URL: http://www.bccancer.bc.ca/HPI/ CancerManagementGuidelines/Gynecology/UterineCervix/of2/Management/RadioTx.htm [accessed May 2, 2003].
15. BC Cancer Agency. Cancer management guidelines for cancer of the vulva [monograph online]. Available from URL: http://www.bccancer.bc.ca/HPI/ CancerManagementGuidelines/Gynecology/Vulva/5Management.htm [accessed Mar 8, 2002].
16. BC Cancer Agency. Cancer management guidelines for cancer of the ovary [monograph online]. Available from URL: http://www.bccancer.bc.ca/HPI/ CancerManagementGuidelines/Gynecology/OvaryEpithelial/Management.htm [accessed Mar 8, 2002].
17. BC Cancer Agency. Cancer management guidelines for cancer of the vagina [monograph online]. Available from URL: http://www.bccancer.bc.ca/HPI/ CancerManagementGuidelines/Gynecology/Vagina/9management.htm [accessed Mar 31, 2004].
18. National Comprehensive Cancer Network. Clinical practice guidelines in oncology-Version 1.2002. Cervical cancer [monograph online]. Available from URL: http://www.nccn.org/professionals/physician_gls/PDF/cervical.pdf [accessed April 15 2002].
19. National Comprehensive Cancer Network. Clinical practice guidelines in oncology-Version 1.2002. Ovarian cancer [monograph online]. Available from URL: http://www.nccn.org/professionals/physician_gls/PDF/ovarian.pdf [accessed May 2, 2003].
20. Australian National Health and Medical Research Council. Guide to the development, implementation and evaluation of clinical practice guidelines. Canberra: National Health and Medical Research Council, 1998.
21. Australian Institute of Health and Welfare and Australasian Association of Cancer Registries. Cancer in Australia 1998. Canberra: Australian Institute of Health and Welfare, 2001.
22. South Australian Cancer Registry. Epidemiology of cancer in South Australia. Adelaide: South Australian Cancer Registry, 2000.
23. Dauplat J, Hacker NF, Nieberg RK, Berek JS, Rose TP, Sagae S. Distant metastases in epithelial ovarian carcinoma. Cancer. 1987;60:1561-1566.
24. Grossi M, Quinn MA, Thursfield VJ, et al. Ovarian cancer: patterns of care in Victoria during 1993-1995. Med J Aust. 2002;177:11-16.
25. National Cancer Institute. Surveillance, Epidemiology and End Results (SEER) Program public-use CD-ROM (1973-1995) [computer database]. Bethesda: National Cancer Institute, 1998.
26. American College of Surgeons. National cancer database [database online]. Available from URL: http://www.facs.org/cancer/ncdb/index.html [accessed March 2003].
27. Munoz KA, Harlan LC, Trimble EL. Patterns of care for women with ovarian cancer in the United States. J Clin Oncol. 1997;15:3408-3415.
28. Priestman TJ, Dunn J, Brada M, Rampling R, Baker PG. Final results of the Royal College of Radiologists' trial comparing two different radiotherapy schedules in the treatment of cerebral metastases. Clin Oncol (R Coll Radiol). 1996;8:308-315.
29. Kurtz JM, Gelber R, Brady LW, Carella RJ, Cooper JS. The palliation of brain metastases in a favorable patient population: a randomized clinical trial by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys. 1981;7:891-895.
30. Borgelt B, Gelber R, Kramer S, et al. The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys. 1980;6:1-9.
31. Steenland E, Leer J, Van-Houwelingen H, et al. The effect of a single fraction compared to multiple fractions on painful bone metastases: a global analysis of the Dutch Bone Metastasis Study. Radiother Oncol. 1999;52:101-109.
32. Nielsen OS, Bentzen SM, Sandberg E, et al. Randomised trial of single dose versus fractionated palliative radiotherapy of bone metastases. Radiother Oncol. 1998;47:233-240.
33. Tong D, Gillick L, Hendrickson FR. The palliation of symptomatic osseous metastases. The final results of the study by the Radiation Therapy Oncology Group. Cancer. 1982;50:893-899.
34. Berek JS, Hacker NF, editors. Practical gynecologic oncology (3rd edition). Philadelphia: Lippincott Williams & Wilkins, 2000.
35. Homesley HD, Bundy BN, Sedlis A, et al. Radiation therapy versus pelvic node resection for carcinoma of the vulva with positive groin nodes. Obstet Gynecol. 1983;16:179-189.
36. Roila F, Lupattelli M, Sassi M, et al. Intra and interobserver variability in cancer patients' performance status assessed according to Karnofsky and ECOG scales. Ann Oncol. 1991;2:437-439.
37. Fuller AF, Elliot N, Kosloff C, Hoskins WJ, Lewis JL. Determinants of increased risk for recurrence in patients undergoing radical hysterectomy for Stage IB and IIA carcinoma of the cervix. Gynecol Oncol. 1989;33:34-39.
38. Landoni F, Maneo A, Colombo A, et al. Randomised study of radical surgery versus radiotherapy for Stage Ib-IIa cervical cancer. Lancet. 1997;350:535-540.
39. Kim SM, Choi HS, Byun JS. Overall 5-year survival rate and prognostic factors in patients with Stage IB and IIA cervical cancer treated by radical hysterectomy and pelvic lymph node dissection. Int J Gynecol Cancer. 2000;10:305-312.
40. Kamura T, Tsukamoto N, Tsuruchi N, et al. Multivariate analysis of the histopathologic prognostic factors of cervical cancer in patients undergoing radical hysterectomy. Cancer. 1992;69:181-186.
41. Estape RE, Angioli R, Madrigal M, et al. Close vaginal margins as a prognostic factor after radical hysterectomy. Gynecol Oncol. 1998;68:229-232.
42. Delgado G, Bundy B, Zaino RJ, Sevin BU, Creasman WT, Major F. Prospective surgical-pathological study of disease-free interval in patients with Stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol. 1990;38:352-357.
43. Kridelka FJ, Berg DO, Neuman M, et al. Adjuvant small field pelvic radiation for patients with high risk, Stage IB lymph node negative cervix carcinoma after radical hysterectomy and pelvic node dissection. Cancer. 1999;86:2059-2065.
44. Samlal RA, van der Velden J, Ten Kate FJ, Schilthuis MS, Hart AA, Lammes FB. Surgical pathologic factors that predict recurrence in Stage IB and IIA cervical carcinoma patients with negative pelvic lymph nodes. Cancer. 1997;80:1234-1240.
45. Saphner T, Gallion HH, Van Nagell JR, Kryschio R, Patchell RA. Neurologic complications of cervical cancer. A review of 2261 cases. Cancer. 1989;64:1147-1151.
46. Wang CJ, Lai CH, Huang HJ, et al. Recurrent cervical carcinoma after primary radical surgery. Am J Obstet Gynecol. 1999;181:518-524.
47. Fagundes H, Perez CA, Grigsby PW, Lockett MA. Distant metastases after irradiation alone in carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys. 1992;24:197-204.
48. Solomayer EF, Diel IJ, Meyberg GC, Gollan C, Bastert G. Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis. Breast Cancer Res Treat. 2000;59:271-278.
49. Hacker NF, Berek JS, Lagasse LD, Nieberg RK, Leuchter RS. Individualization of treatment for Stage I squamous cell vulvar carcinoma. Obstet Gynecol. 1984;63:155-162.
50. Stehman FB, Bundy BN, Thomas G, et al. Groin dissection versus groin radiation in carcinoma of the vulva: a Gynecologic Oncology Group study. Int J Radiat Oncol Biol Phys. 1992;24:389-396.